JUBBONTI
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 May 2028: the §71 affidavit of use).
Record
- Serial number
- 79324784
- Registration number
- 6726949
- Mark type
- Word mark
- Filed
- 28 Jul 2021
- Published for opposition
- 01 Mar 2022
- Registered
- 24 May 2022
- Next maintenance filing
- §71 affidavit of use, due by 24 May 2028 (grace period to 24 Nov 2028)
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Sandoz AG, CH
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 03 Sept 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Jan 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 11 Sept 2022 — NOTIFICATION PROCESSED BY IB
- 19 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Aug 2022 — FINAL DISPOSITION PROCESSED
- 23 Jun 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2022 — PUBLISHED FOR OPPOSITION
- 28 Feb 2022 — NOTIFICATION PROCESSED BY IB
- 09 Feb 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Feb 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 09 Feb 2022 — NOTICE OF PUBLICATION
- 24 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2022 — ASSIGNED TO EXAMINER
- 09 Nov 2021 — APPLICATION FILING RECEIPT MAILED